Showing results (111-120 of 150) with videos related to
Sort By:
Pageof 15
The Lancet. Infectious Diseases|February 15, 2021
QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trialKelly E Dooley, Susan L Rosenkranz, Francesca Conradie, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2020
Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy InitiationTrevor A Crowell, Justin Ritz, Robert W Coombs, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2019
A Parsimonious Host Inflammatory Biomarker Signature Predicts Incident Tuberculosis and Mortality in Advanced Human Immunodeficiency VirusYukari C Manabe, Bruno B Andrade, Nikhil Gupte, et al.AIDS (London, England)|February 7, 2014
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxisMarc M Solomon, Javier R Lama, David V Glidden, et al.Open Forum Infectious Diseases|July 28, 2015
A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational SettingsKristine M Erlandson, Sineenart Taejaroenkul, Laura Smeaton, et al.Nutrients|November 18, 2014
Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapyRupak Shivakoti, Nikhil Gupte, Wei-Teng Yang, et al.Lancet (London, England)|November 18, 2008
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialSusan P Buchbinder, Devan V Mehrotra, Ann Duerr, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2019
Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017)Albert Y Liu, Aliza Norwood, Holly Gundacker, et al.Science Translational Medicine|September 14, 2012
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with menPeter L Anderson, David V Glidden, Albert Liu, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 18, 2014
Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx StudyAlbert Liu, David V Glidden, Peter L Anderson, et al.Pageof 15